Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an American ophthalmological society thesis)

Transactions of the American Ophthalmological Society

Volumn 112, Issue , 2014, Pages 103-115

  Tsang, Stephen H ^a,b   Chan, Lawrence ^b   Tsai, Yi Ting ^b   Wu, Wen Hsuan ^b   Hsu, Chun Wei ^b   Yang, Jin ^b,c   Tosi, Joaquin ^b,e   Wert, Katherine J ^b,f   Davis, Richard J ^b,g   Mahajan, Vinit B ^d  

^a Department of Medicine   (United States)

^b Tianjin Medical University Eye Hospital ^*  (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF IOWA   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^g Neural Stem Cell Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; PHOSPHODIESTERASE VI; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN S6; SHORT HAIRPIN RNA; TUBERIN; PHOSPHOTRANSFERASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PHOTORECEPTOR OUTER SEGMENT; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RETINITIS PIGMENTOSA; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; APOPTOSIS; DISEASE MODEL; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; GENE SILENCING; MICE; MICE, MUTANT STRAINS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTO-ONCOGENE PROTEINS C-AKT; RETINITIS PIGMENTOSA; RIBOSOMAL PROTEIN S6; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84922534728     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Berson EL. Retinitis pigmentosa: The Friedenwald lecture. Invest Ophthal Vis Sci1993;34(5):1659-1676.
2. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet2006;368(9549):1795-1809.
3. Sohocki MM, Daiger SP, Bowne SJ, et al. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat2001;17(1):42-51.
4. Dinculescu A, Glushakova L, Min SH, Hauswirth WW. Adeno-associated virus-vectored gene therapy for retinal disease. Hum Gene Ther2005;16(6):649-663.
5. Schlichtenbrede FC, da Cruz L, Stephens C, et al. Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy. J Gene Med2003;5(9):757-764.
6. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med2008;358(21):2231-2239.
7. Jacobson SG, Cideciyan AV, Aleman TS, et al. Photoreceptor layer topography in children with Leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci2008;49(10):4573-4577.
8. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med2008;358(21):2240-2248.
9. Cideciyan AV, Jacobson SG, Beltran WA, et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci U S A2013;110(6):E517-525.
10. Cepko CL, Vandenberghe LH. Retinal gene therapy coming of age. Hum Gene Ther2013;24(3):242-244.
11. McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP. Mutation spectrum of the gene encoding the b subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Nat Acad Sci U S A1995;92:3249-3253.
12. Bird AC. Retinal photoreceptor dystrophies: the LI. Edward Jackson Memorial Lecture. Am J Ophthalmol1995;119:543-562.
13. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol2007;125(2):151-158.
14. Davis JW, Nakanishi H, Kumar VS, et al. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. J Urol2008;179(6):2187-2191; discussion 2191.
15. Tsang SH, Tsui I, Chou CL, et al. A novel mutation and phenotypes in phosphodiesterase 6 deficiency. Am J Ophthalmol2008;146(5):780-788.
16. Woodruff ML, Janisch KM, Peshenko IV, Dizhoor AM, Tsang SH, Fain GL. Modulation of phosphodiesterase6 turnoff during background illumination in mouse rod photoreceptors. J Neurosci2008;28(9):2064-2074.
17. Janisch KM, Kasanuki JM, Naumann MC, et al. Light-dependent phosphorylation of the gamma subunit of cGMP-phophodiesterase (PDE6gamma) at residue threonine 22 in intact photoreceptor neurons. Biochem Biophys Res Commun2009;390(4):1149-1153.
18. Yang J, Naumann MC, Tsai YT, et al. Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors. PLoS One2012;7(8):e43889. doi:10.1371/journal.pone.0043889.
19. Sancho-Pelluz J, Tosi J, Hsu CW, et al. Mice with a D190N mutation in the gene encoding rhodopsin: a model for human autosomal-dominant retinitis pigmentosa. Mol Med2012;18(1):549-555.
20. Tosi J, Davis RJ, Wang NK, Naumann M, Lin CS, Tsang SH. shRNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa. J Cell Mol Med2011;15(8):1778-1787.
21. Tosi J, Sancho-Pelluz J, Davis RJ, et al. Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa. Exp Biol Med (Maywood)2011; 236(10):1211-1217.
22. Wert KJ, Davis RJ, Sancho-Pelluz J, Nishina PM, Tsang SH. Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa. Hum Mol Genet2013;22(3):558-567.
23. Keeler CE. The inheritance of a retinal abnormality in white mice. Proc Natl Acad Sci U S A1924;10:329-333.
24. Keeler C. Retinal degeneration in the mouse is rodless retina. J Hered1966;57:47-50.
25. Tsang SH, Gouras P. Molecular physiology and pathology of the retina. In: Tasman W, Jaeger EA, eds. Duane’s Clinical Ophthalmology. Vol 3. Philadelphia: Lippincott; 1996:chap 2.
26. Tsang SH, Burns ME, Calvert PD, et al. Role for the target enzyme in deactivation of photoreceptor G protein in vivo. Science1998;282(5386):117-121.
27. Tsang SH, Woodruff ML, Janisch KM, Cilluffo MC, Farber DB, Fain GL. Removal of phosphorylation sites of gamma subunit of phosphodiesterase 6 alters rod light response. J Physiol2007;579(Pt 2):303-312.
28. Tsang S, Salchow D, Jiang M, et al. Toward repair of retinal degenerations with differentiated and embryonic stem (ES) cells. Am J Hum Genet2001;69:A2836.
29. Tsang SH, Yamashita CK, Lee WH, et al. The positive role of the carboxyl terminus of the gamma subunit of retinal cGMP-phosphodiesterase in maintaining phosphodiesterase activity in vivo. Vision Res2002;42(4):439-445.
30. Fain GL, Matthews HR, Cornwall MC, Koutalos Y. Adaptation in vertebrate photoreceptors. Physiol Rev 2001;81(1):117-151.
31. Stryer L. Visual excitation and recovery. J Biol Chem1991;266:10711-10714.
32. Yarfitz S, Hurley JB. Transduction mechanisms of vertebrate and invertebrate photoreceptors. J Biol Chem1994;269(May 20):14329-14332.
33. Burns ME, Baylor DA. Activation, deactivation, and adaptation in vertebrate photoreceptor cells. Annu Rev Neurosci2001;24:779-805.
34. Burns ME, Arshavsky VY. Beyond counting photons: trials and trends in vertebrate visual transduction. Neuron2005;48(3):387-401.
35. Fung BK-K, Hurley JB, Stryer L. Flow of information in the light-triggered cyclic nucleotide cascade of vision. Proc Natl Acad Sci U S A1981;78:152-156.
36. Arshavsky VY, Lamb TD, Pugh EN Jr. G proteins and phototransduction. Annu Rev Physiol2002;64:153-187.
37. Zhang X, Cote RH. cGMP signaling in vertebrate retinal photoreceptor cells. Front Biosci 2005;10:1191-1204.
38. Baehr W, Devlin MJ, Applebury ML. Isolation of bovine ROS phosphiesterase. J Biol Chem 1979;254:11669-11677.
39. Fung BKK, Young JH, Yamane HK, Griswold-Prenner I. Subunit stoichiometry of retinal rod cGMP phosphodiesterase. Biochemistry1990;29:2657-2664.
40. Guo LW, Grant JE, Hajipour AR, et al. Asymmetric interaction between rod cyclic GMP phosphodiesterase gamma subunits and alpha/beta subunits. J Biol Chem2005;280(13):12585-12592.
41. Guo LW, Muradov H, Hajipour AR, Sievert MK, Artemyev NO, Ruoho AE. The inhibitory gamma subunit of the rod cGMP phosphodiesterase binds the catalytic subunits in an extended linear structure. J Biol Chem2006;281(22):15412-15422.
42. Farber DB, Lolley RN. Enzyme basis for cyclic GMP accumulation in degenerative photoreceptor cells of mouse retina. J Cyclic Nucleotide Res1976;2:139-148.
43. Farber DB. From mice to men: the cyclic GMP phosphodiesterase gene in vision and disease. The Proctor Lecture. InvestOpthalmol Vis Sci1995;36(Feb):263-275.
44. Cepko CL. Effect of gene expression on cone survival in retinitis pigmentosa. Retina2005;25(8 Suppl):S21-S24.
45. Farber DB, Flannery JG, Bowes-Rickman C. The rd mouse story: seventy years of research on an animal model of inherited retinal degeneration. Prog Retinal Res1994;13:31-64.
46. Rohrer B, Pinto FR, Hulse KE, Lohr HR, Zhang L, Almeida JS. Multidestructive pathways triggered in photoreceptor cell death of the rd mouse as determined through gene expression profiling. J Biol Chem2004;279(40):41903-41910.
47. Lohr HR, Kuntchithapautham K, Sharma AK, Rohrer B. Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death. Exp Eye Res2006;83(2):380-389.
48. Takano Y, Ohguro H, Dezawa M, et al. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse. Biochem Biophys Res Commun2004;313(4):1015-1022.
49. Farber DB, Lolley RN. Cyclic guanosine monophosphate: elevations in degenerating photoreceptor cells of the C3H mouse retina. Science1974;186:449-451.
50. Hart AW, McKie L, Morgan JE, et al. Genotype-phenotype correlation of mouse pde6b mutations. Invest Ophthalmol Vis Sci2005;46(9):3443-3450.
51. Davis R, Tosi J, Janisch K, et al. Functional rescue of degenerating photoreceptors in mice homozygous for a hypomorphic cGMP phosphodiesterase 6 b allele (Pde6bH620Q). Invest Ophthalmol Vis Sci2008;49(11):5067-5076.
52. Azadi S, Johnson LE, Paquet-Durand F, et al. CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina. Brain Res2007;1129(1):116-129.
53. Jomary C, Cullen J, Jones SE. Inactivation of the Akt survival pathway during photoreceptor apoptosis in the retinal degeneration mouse. Invest Ophthalmol Vis Sci2006;47(4):1620-1629.
54. Johnson LE, van Veen T, Ekstrom PA. Differential Akt activation in the photoreceptors of normal and rd1 mice. Cell Tissue Res2005;320(2):213-222.
55. Hauck SM, Ekstrom PA, Ahuja-Jensen P, et al. Differential modification of phosducin protein in degenerating rd1 retina is associated with constitutively active Ca2+/calmodulin kinase II in rod outer segments. Mol Cell Proteomics2006;5(2):324-336.
56. Roux PP, Topisirovic I. Regulation of mRNA translation by signaling pathways. Cold Spring Harb Perspect Biol 2012;4(11).
57. van Baal JW, Diks SH, Wanders RJ, et al. Comparison of kinome profiles of Barrett’s esophagus with normal squamous esophagus and normal gastric cardia. Cancer Res2006;66(24):11605-11612.
58. Diks SH, Kok K, O’Toole T, et al. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J Biol Chem2004;279(47):49206-49213.
59. Davis RJ, Hsu CW, Tsai YT, et al. Therapeutic margins in a novel preclinical model of retinitis pigmentosa. J Neurosci2013;33(33):13475-13483.
60. Tosi J, Janisch KM, Wang NK, et al. Cellular and molecular origin of circumpapillary dysgenesis of the pigment epithelium. Ophthalmology2009;116(5):971-980.
61. Tosi J, Davis RJ, Wang NK, Naumann M, Lin CS, Tsang SH. shRNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa. J Cell Mol Med2011;15(8):1778-1887.
62. Tsang SH, Woodruff ML, Chen CK, et al. GAP-independent termination of photoreceptor light response by excess gamma subunit of the cGMP-phosphodiesterase. J Neurosci2006;26(17):4472-4480.
63. Tsang SH, Woodruff ML, Hsu CW, et al. Function of the asparagine 74 residue of the inhibitory gamma-subunit of retinal rod cGMP-phophodiesterase (PDE) in vivo. Cell Signal2011;23(10):1584-1589.
64. Tsang SH, Woodruff ML, Jun L, et al. Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness. Hum Mutat2007;28(3):243-254.
65. Tsang SH, Woodruff ML, Lin CS, et al. Effect of the ILE86TER mutation in the gamma subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling. Cell Signal2012;24(1):181-188.
66. Wert KJ, Sancho-Pelluz J, Tsang SH. Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa. Hum Mol Genet2014;23(2):514-523.
67. Lolley R, Farber D, Rayborn M, Hollyfield J. Cyclic GMP accumulation causes degeneration of photoreceptor cells: simulation of an inherited disease. Science1977;196:664-666.
68. Wert KJ, Skeie JM, Davis RJ, Tsang SH, Mahajan VB. Subretinal injection of gene therapy vectors and stem cells in the perinatal mouse eye. J Vis Exp 2012 Nov 25;(69).
69. Tsang S, Woodruff M, Lin C, et al. Effect of the ILE86TER mutation in the γ subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling. Cell Signal2012;24(1):181-188.
70. Janisch KM, Kasanuki JM, Naumann MC, et al. Light-dependent phosphorylation of the gamma subunit of cGMP-phosphodiesterase (PDE6gamma) at residue threonine 22 in intact photoreceptor neurons. Biochem Biophys Res Commun2009;390(4):1149-1153.
71. Woodruff ML, Janisch KM, Peshenko IV, Dizhoor AM, Tsang SH, Fain GL. Modulation of phosphodiesterase6 turnoff during background illumination in mouse rod photoreceptors. J Neurosci2008;28(9):2064-2074.
72. Tosi J, Wang NK, Zhao J, et al. Rapid and noninvasive imaging of retinal ganglion cells in live mouse models of glaucoma. Mol Imaging Biol2010;12(4):386-393.
73. Wang NK, Tosi J, Kasanuki JM, et al. Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa. Transplantation2010;89(8):911-919.
74. Mahajan VB, Skeie JM, Assefnia AH, Mahajan M, Tsang SH. Mouse eye enucleation for remote high-throughput phenotyping. J Vis Exp2011 Nov 19;(57).
75. Freilinger A, Rosner M, Hengstschlager M. Tuberin negatively affects BCL-2’s cell survival function. Amino Acids2006;30(4):391-396.
76. Rosner M, Freilinger A, Hengstschlager M. Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene2007;26(4):521-531.
77. Kolb TM, Duan L, Davis MA. Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis. Toxicol Sci2005;88(2):331-339.
78. Punzo C, Kornacker K, Cepko CL. Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa. Nat Neurosci2009;12(1):44-52.
79. Ruvinsky I, Sharon N, Lerer T, et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev2005;19(18):2199-2211.
80. Fain GL, Lisman JE. Light, Ca2+, and photoreceptor death: new evidence for the equivalent- light hypothesis from arrestin knockout mice. Invest Ophthalmol Vis Sci1999;40(12):2770-2772.
81. Tsang SH, Chen J, Yamashita CK, et al. Apoptotic photoreceptor death in gene targeted mutant mice and its deceleration by gene therapy. Am J Hum Genet1996;59(Oct):A54.
82. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011;12(1):21-35.
83. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opinion Cell Biol2005;17(6):596-603.
84. Yu Y, Yoon SO, Poulogiannis G, et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science2011;332(6035):1322-1326.
85. Ekim B, Magnuson B, Acosta-Jaquez HA, Keller JA, Feener EP, Fingar DC. mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression. Mol Cell Biol2011;31(14):2787-2801.
86. Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell2003;4(2):147-158.